Related Experiment Video
Updated: Jan 11, 2026
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Multisite Occupancy and Multidimensional Optimization: Design and Evaluation of Piperazine-Thioureidobenzamide
Minghui Liang1, Yutong Dou2, Jian Zhang1
1School of Pharmacy, Shandong Second Medical University, Weifang 261053, Shandong, PR China.
Abstract:
Hepatitis B virus (HBV) capsid assembly modulators are a promising class of agents for chronic HBV infection. Thioureidobenzamide compound 17i exhibits potent anti-HBV activity but suffers from poor water solubility, high cytotoxicity, and limited drug-like properties. Herein, we report the design of piperazine-thioureidobenzamide derivatives via multisite occupancy and multidimensional optimization strategies. The representative compound 35a exhibited potent anti-HBV activity and low cytotoxicity in HepAD38 cells (EC50 = 0.020 μM, CC50 > 100 μM) and HLCZ01 cells (EC50 = 0.024 μM, CC50 > 100 μM). Molecular dynamics simulations revealed that 35a retained critical hydrogen bonds with Trp-102, Thr-128, and Leu-140, while forming new hydrogen bonds with Ser-106, Thr-142, and Asn-136. Multidimensional optimization endowed 35a with improved solubility, ideal LogP and high plasma stability. In HBV carrier mouse models, 35a inhibited viral replication more effectively than 17i, highlighting its potential as a promising candidate drug for further development.
More Related Videos
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
